Haemonetics Q3 EPS $0.94 Beats $0.76 Estimate, Sales $258.97M Beat $255.4M Estimate

Haemonetics (NYSE:HAE) reported quarterly earnings of $0.94 per share which beat the analyst consensus estimate of $0.76 by 23.68 percent. This is a 49.21 percent increase over earnings of $0.63 per share from the same

Benzinga · 02/04/2020 11:15

Haemonetics (NYSE:HAE) reported quarterly earnings of $0.94 per share which beat the analyst consensus estimate of $0.76 by 23.68 percent. This is a 49.21 percent increase over earnings of $0.63 per share from the same period last year. The company reported quarterly sales of $258.97 million which beat the analyst consensus estimate of $255.4 million by 1.40 percent. This is a 4.70 percent increase over sales of $247.356 million the same period last year.